China - China – Opportunity in the research fields of commercialisation herbal medicine

Description

This Beijing based Institute of Medicinal Plant Development, affiliated to a national level of medical sciences academy, Herbal products (HPs) is looking for UK Biotech & Pharma business partners with the following objective:

The major part of healthcare for >70% of the population of developing countries, and developed countries are becoming conscious of the potential economic and clinical value of HPs in primary health care. Target on the HPs in prevention and treatment of senile diseases, such as cardio-cerebro-vascular and neuro-psychological diseases.

By working with potential UK partner, a China-UK team will be formed to identification and harmonisation standards on efficacy, safety and quality control for registration of HPs, in order that HPs could be commercialised on market.

The major tasks will be:
1.data collection of herbal products on aged diseases, including neurodegenerative and cardiovascular diseases, cancer etc., in EU/UK and Chinese markets;
2.studing regulations, technical requirements of quality control, efficacy and safety evaluation for registration HPs (food supplements, cosmetics, over the counter (OTC) and prescription drugs) in UK/EU and China;
3. 2-3 herbal products will be specified as model samples for registration research systematically, following requirements from both of EU/UK and Chinese authorities, including pre-clinical research and clinical trial.

To find out more, please register your interest with our team in China.

The China-Britain Business Council (‘CBBC’) is a membership organisation and UKTI’s chosen partner in China to deliver trade services. To find out more about CBBC please visit www.cbbc.org.

Opportunity closing date

30 October 2016

Value of contract

to be confirmed